Skip to main content

Neuman John's Form 4 filing

SeaStar Medical Holding CorpICU · filed Feb 27, 2025

Accession no.
0001213900-25-017946
Filed
Feb 27, 2025
Trade date
Jun 14-Dec 11, 2024
Filing delay
258 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions. Open-market purchases total $153.2K. It was filed 258 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Neuman JohnCIK 0002026279Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 14, 2024Common Stock, par value $0.0001 per sharePPurchaseAcquired+10,000$3.69F1+$36,90010,000Direct
Jun 17, 2024Common Stock, par value $0.0001 per sharePPurchaseAcquired+10,000$4.35F2+$43,50020,000Direct
Aug 15, 2024Common Stock, par value $0.0001 per sharePPurchaseAcquired+10,000$5.24F3+$52,40030,000Direct
Dec 11, 2024Common Stock, par value $0.0001 per sharePPurchaseAcquired+10,000$2.04F4+$20,40040,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

1. The price reported in Column 4 is a weighted average price of $3.6905. These shares were purchased in multiple transactions at prices ranging from $3.67 to $3.71, inclusive. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Referenced by the price of 1 transaction in Table I.

F2

2. The price reported in Column 4 is a weighted average price of $4.3521. These shares were purchased in multiple transactions at prices ranging from $4.29 to $4.37, inclusive. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Referenced by the price of 1 transaction in Table I.

F3

3. The price reported in Column 4 is a weighted average price of $5.2396. These shares were purchased in multiple transactions at prices ranging from $5.19 to $5.24, inclusive. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

4. The price reported in Column 4 is a weighted average price of $2.0405. These shares were purchased in multiple transactions at prices ranging from $2.01 to $2.06, inclusive. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Referenced by the price of 1 transaction in Table I.

Remarks

These transactions are being reported late due to an inadvertent administrative error.

Read the full filing on SEC EDGAR (opens in a new tab)